Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer.
- Published in:
- Oncogene, 2008, v. 27, n. 57, p. 7201, doi. 10.1038/onc.2008.320
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2008 AND VI 27 AND IP 57
Results: 8
1
2
Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT.
- Published in:
- Oncogene, 2008, v. 27, n. 57, p. 7171, doi. 10.1038/onc.2008.321
- By:
- Publication type:
- Article
3
RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin.
- Published in:
- Oncogene, 2008, v. 27, n. 57, p. 7139, doi. 10.1038/onc.2008.325
- By:
- Publication type:
- Article
4
Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.
- Published in:
- Oncogene, 2008, v. 27, n. 57, p. 7212, doi. 10.1038/onc.2008.326
- By:
- Publication type:
- Article
5
Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer.
- Published in:
- Oncogene, 2008, v. 27, n. 57, p. 7180, doi. 10.1038/onc.2008.327
- By:
- Publication type:
- Article
6
Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma.
- Published in:
- Oncogene, 2008, v. 27, n. 57, p. 7162, doi. 10.1038/onc.2008.329
- By:
- Publication type:
- Article
7
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.
- Published in:
- Oncogene, 2008, v. 27, n. 57, p. 7192, doi. 10.1038/onc.2008.356
- By:
- Publication type:
- Article
8
Colorectal cancer cells with the BRAF<sup>V600E</sup> mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.
- Published in:
- Oncogene, 2008, v. 27, n. 57, p. 7150, doi. 10.1038/onc.2008.335
- By:
- Publication type:
- Article